Catalogo Ricerca

Catalogo Ricerca: [19041] Home page macrotipologia

Sfoglia

1 Contributo su Rivista 16720
- 1.1 Articolo in rivista 14946
- 1.2 Recensione in rivista 126
- 1.3 Scheda bibliografica 0
- 1.4 Nota a sentenza 8
- 1.5 Abstract in rivista 1523
- 1.6 Traduzione in rivista 0
- 1.7 Lettera 62
- 1.8 Materiale editoriale 55

2 Contributo in Volume 795

3 Libro 64

4 Contributo in Atti di Convegno (Proceeding) 1405
- 4.1 Contributo in Atti di convegno 545
- 4.2 Abstract in Atti di convegno 696
- 4.3 Poster 164

5 Altro 24
- 5.01 Composizione 0
- 5.02 Disegno 0
- 5.03 Design 0
- 5.04 Performance 0
- 5.05 Esposizione 0
- 5.06 Mostra 0
- 5.07 Manufatto 0
- 5.08 Prototipo d'arte e relativi progetti 0
- 5.09 Cartografia 0
- 5.10 Banca dati 0
- 5.11 Software 0
- 5.12 Altro 24
- 5.13 Progetto architettonico 0

6 Brevetti 33
- 6.1 Brevetto 33

7 Curatele 0
- 7.1 Curatela 0

8 Tesi di dottorato 0
- 8.1 Tesi di dottorato 0

Prodotti recenti

Dual antiplatelet therapy duration after percutaneous coronary intervention with drug-eluting stents: how short can we go?

Current guidelines recommend a duration of dual antiplatelet therapy (DAPT) with aspirin and oral P2Y12 receptor inhibitors following percutaneous coronary intervention (PCI) with second-generation drug-eluting stents (DES) of 6 months for most patients with stable coronary disease and of 12 months for most patients with acute coronary syndromes. Large evidence from randomised clinical trials of shorter DAPT regimens after PCI with newer-generation DES is now emerging in heterogenous patient ...

[Percutaneous mitral valve repair in acute mitral regurgitation]

Acute mitral regurgitation is a life-threatening pathology. Nowadays, percutaneous mitral valve repair with the MitraClip device offers, in selected patients, a safe and effective therapeutic alternative to open surgery. Hereby, we report the case of an 82-year-old woman with lateral ST-elevation myocardial infarction determining severe acute mitral regurgitation, who was treated with an urgent MitraClip procedure. Moreover, we discuss echocardiographic assessment of acute mitral regurgitatio...

The Placebo Effect on Symptoms, Quality of Life, and Functional Outcomes in Patients With Angina Pectoris: A Meta-analysis of Randomized Placebo-Controlled Trials

The placebo effect is a well described phenomenon in blinded studies evaluating antianginal therapeutics, although its effect on clinical research metrics remains unknown. We conducted a systematic review and meta-analysis to quantify the effect of placebo on end points of symptoms, life quality, and functional outcomes in randomized placebo-controlled trials (RCTs) of symptomatic stable coronary artery disease.

MicroRNA-132 Inhibition Prevents Myocardial Hypertrophy and Heart Failure in Pigs: Making Sense Out of Antisense

Association Between Colchicine Treatment and Clinical Outcomes in Patients with Coronary Artery Disease: Systematic Review and Meta-analysis

Background: The authors examined the association between colchicine treatment and clinical outcomes in patients with coronary artery disease. Methods: They performed a meta-analysis of randomised controlled trials (RCTs) involving patients with coronary artery disease receiving addon colchicine to standard treatment compared with standard treatment. They used a mixed-effects Poisson regression model with random intervention effects to estimate the pooled incidence rate ratios (IRR) with 95% C...

Scopri

Accesso al fulltext

no fulltext17565
reserved1261
open215